For the Inventor, By the Inventor

Enter inventor name

Boston, MA, United States of America

Thomas Edward Hughes

USPTO Granted Patents = 15 (Patent Applications = 22)

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 1)

Average Co-Inventor Count = 1.7

ph-index = 7

Forward Citations = 155(Granted Patents)

Location History:

Concord, MA (US) (2011 - 2014)
Boston, MA (US) (2015 - 2019)

Company Filing History:

Vanderbilt University

Novartis Pharma Ag

where one patent can have more than one assignee

Years Active: 2011-2019

Loading Chart...

Loading Chart...

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10406134 - Methods of treating an overweight subject (2019-09-10),

2. 10231946 - Methods of treating ischemic organ damage and other disorders (2019-03-19),

3. 10064839 - Methods of treating liver diseases (2018-09-04),

4. 9849106 - Methods of treating impaired wound healing (2017-12-26),

5. 9649293 - Methods of treating an overweight subject (2017-05-16),

6. 9597309 - Methods of treating renal disease and other disorders (2017-03-21),

7. 9561209 - Methods of treating liver diseases (2017-02-07),

8. 9446016 - Methods of treating age related disorders (2016-09-20),

9. 9173865 - Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol (2015-11-03),

10. 9000035 - Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol (2015-04-07),

11. 8980946 - Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol (2015-03-17),

12. 8642650 - Methods of treating an overweight or obese subject (2014-02-04),

13. 8367721 - Methods of treating an overweight or obese subject (2013-02-05),

14. 8143217 - Use of DPP-IV inhibitor to reduce hypoglycemic events (2012-03-27),

15. 7935723 - Use of organic compounds (2011-05-03),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…